Please login to the form below
Cymbalta
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Cymbalta was produced by Lilly and Shionogi.
Daily Brief: another departure at Gilead, veteran researcher to head up Karuna
Steven Paul, a veteran researcher who played a key role in developing Lilly’s antipsychotic and depression blockbuster drugs such as Zyprexa and Cymbalta is to head up efforts to find
Lilly mulls divestment of its animal health operations
Alimta (pemetrexed) and antidepressant Cymbalta (duloxetine) resulting from generic competition.
Daiichi drug hits mark in shingles pain, but misses in other indications
At the moment, there are just three approved drugs for fibromyalgia - Lyrica, Eli Lilly's Cymbalta (duloxetine) and Allergan's Savella (milnacipran) - and while these have been shown to reduce pain
Lilly’s president and chief executive John Lechleiter to retire
raloxifene) and antidepressant Cymbalta (duloxetine) have also expired.
UK court backs Actavis in dispute over Lilly's Alimta
Maintaining Alimta's revenue stream is a priority for Lilly as it weathers the loss of patent protection for other brands, including osteoporosis drug Evista (raloxifene) and antidepressant Cymbalta (duloxetine) and
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Embattled Biogen talks up Aduhelm
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Future of MHRA uncertain amid Brexit-fuelled shake up
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Valneva’s COVID-19 vaccine to be tested in older people
- Live Webinar: Driving Healthcare Decisions with Natural Language Processing
- UK announces COVID boosters for a “bumpy winter” ahead
- Orphan status in Europe for lymphoma drug Zynlonta
- To avoid making mistakes when applying behavioural insights in healthcare, we need to understand why people do what they do
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- Health literacy in the time of COVID-19
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Ovid wins Communiqué Small Consultancy of the Year award at Communiqué 2021
- Lucid Group celebrates a double win at Communiqué 2021
- New data advances AstraZeneca’s “revolution in oncology”
- McCann wins D&I leadership award at Communiqué 2021
PMHub
Madmicrobe Studios - Medical Animation
MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
